F&P Healthcare: don’t mention the tariffs!

F&P Healthcare: don’t mention the tariffs!
F&P Healthcare CEO Lewis Gradon - playing the long game (Image: Supplied)
Pattrick Smellie
Fisher & Paykel Healthcare senior leaders were keeping their heads down on the potential impact of US tariffs on its business during an investors’ call on the company’s stellar half-year results.“We really don't want to be drawn into any speculation on that whatsoever,” said managing director and chief executive, Lewis Gradon.However, there were hints that its newly opened Chinese plant is unlikely to be sending products to the US, since the Guangzhou facility is primarily expected to service the Chinese mar...

More Markets

NZ sharemarket up 0.4% after a2 Milk surge
Markets Market Close

NZ sharemarket up 0.4% after a2 Milk surge

The S&P/NZX 50 Index closed at 12,266.25, gaining 57.2 points or 0.47%.

Goldman Sachs downgrades Fletcher Building to sell
Markets

Goldman Sachs downgrades Fletcher Building to sell

Goldman Sach analysts have a 12-month target price of A$2.85 ($3.14).

Rayonier exits NZ with $1.2b forestry sale
Primary Sector

Rayonier exits NZ with $1.2b forestry sale

An investment firm bought the stake, which included 116,145 hectares of forestry.

NZME board told 'compromise or be rolled'
Markets

NZME board told 'compromise or be rolled'

Minority shareholders are falling in behind billionaire Jim Grenon's board coup.